全文获取类型
收费全文 | 41820篇 |
免费 | 3066篇 |
国内免费 | 1130篇 |
专业分类
耳鼻咽喉 | 476篇 |
儿科学 | 571篇 |
妇产科学 | 482篇 |
基础医学 | 6461篇 |
口腔科学 | 647篇 |
临床医学 | 4174篇 |
内科学 | 7122篇 |
皮肤病学 | 1129篇 |
神经病学 | 2962篇 |
特种医学 | 2412篇 |
外国民族医学 | 5篇 |
外科学 | 4859篇 |
综合类 | 2514篇 |
现状与发展 | 7篇 |
一般理论 | 10篇 |
预防医学 | 2151篇 |
眼科学 | 1168篇 |
药学 | 4137篇 |
15篇 | |
中国医学 | 1170篇 |
肿瘤学 | 3544篇 |
出版年
2024年 | 49篇 |
2023年 | 384篇 |
2022年 | 1260篇 |
2021年 | 1847篇 |
2020年 | 1028篇 |
2019年 | 1169篇 |
2018年 | 1345篇 |
2017年 | 1105篇 |
2016年 | 1456篇 |
2015年 | 2068篇 |
2014年 | 2432篇 |
2013年 | 2695篇 |
2012年 | 3694篇 |
2011年 | 3780篇 |
2010年 | 2256篇 |
2009年 | 1865篇 |
2008年 | 2547篇 |
2007年 | 2377篇 |
2006年 | 2100篇 |
2005年 | 2030篇 |
2004年 | 1569篇 |
2003年 | 1320篇 |
2002年 | 1104篇 |
2001年 | 738篇 |
2000年 | 776篇 |
1999年 | 600篇 |
1998年 | 307篇 |
1997年 | 248篇 |
1996年 | 186篇 |
1995年 | 173篇 |
1994年 | 147篇 |
1993年 | 110篇 |
1992年 | 175篇 |
1991年 | 179篇 |
1990年 | 145篇 |
1989年 | 111篇 |
1988年 | 92篇 |
1987年 | 83篇 |
1986年 | 78篇 |
1985年 | 52篇 |
1984年 | 38篇 |
1983年 | 40篇 |
1982年 | 35篇 |
1981年 | 22篇 |
1980年 | 23篇 |
1979年 | 31篇 |
1978年 | 18篇 |
1977年 | 17篇 |
1976年 | 17篇 |
1974年 | 18篇 |
排序方式: 共有10000条查询结果,搜索用时 31 毫秒
1.
目的探讨脊髓小脑共济失调2型(SCA2)致病基因ATXN2异常等位基因中间重复个体的表型和分子遗传学特点。方法针对2005—2018年中日友好医院神经科运动障碍与神经遗传病研究中心收集的1383个常染色体显性遗传共济失调家系的先证者和部分家系成员,采用荧光标记毛细管电泳片段分析方法进行动态突变检测,对携带ATXN2基因中间重复的个体进行临床表型和遗传特征分析。结果共检出163个家系(包含先证者和家系成员共203人)携带异常扩展的ATXN2基因CAG重复序列,其中93个家系中有107例的异常扩展等位基因重复次数在29~34次之间。在其中的20个亲子对中,父系遗传16个,异常等位基因的代间扩展增加0~28次,母系遗传4个,异常等位基因的代间扩展增加0~4次。结论对于临床拟诊SCA2家系患者,需对其亲代或成年子代个体进行ATXN2基因检测,以免漏诊。动态突变基因检测有助于识别中间重复的个体,对明确家系致病基因和遗传咨询至关重要。 相似文献
2.
Kevin Kyung Ho Choi Santosh Sanagapalli 《World journal of gastrointestinal oncology》2022,14(3):568-586
Barrett's esophagus (BE) is the precursor to esophageal adenocarcinoma (EAC). Progression to cancer typically occurs in a stepwise fashion through worsening dysplasia and ultimately, invasive neoplasia. Established EAC with deep involvement of the esophageal wall and/or metastatic disease is invariably associated with poor long-term survival rates. This guides the rationale of surveillance of Barrett’s in an attempt to treat lesions at an earlier, and potentially curative stage. The last two decades have seen a paradigm shift in management of Barrett’s with rapid expansion in the role of endoscopic eradication therapy (EET) for management of dysplastic and early neoplastic BE, and there have been substantial changes to international consensus guidelines for management of early BE based on evolving evidence. This review aims to assist the physician in the therapeutic decision-making process with patients by comprehensive review and summary of literature surrounding natural history of Barrett’s by histological stage, and the effectiveness of interventions in attenuating the risk posed by its natural history. Key findings were as follows. Non-dysplastic Barrett’s is associated with extremely low risk of progression, and interventions cannot be justified. The annual risk of cancer progression in low grade dysplasia is between 1%-3%; EET can be offered though evidence for its benefit remains confined to highly select settings. High-grade dysplasia progresses to cancer in 5%-10% per year; EET is similarly effective to and less morbid than surgery and should be routinely performed for this indication. Risk of nodal metastases in intramucosal cancer is 2%-4%, which is comparable to operative mortality rate, so EET is usually preferred. Submucosal cancer is associated with nodal metastases in 14%-41% hence surgery remains standard of care, except for select situations. 相似文献
3.
4.
Moderate sedatives have been increasingly used to improve patient comfort during flexible bronchoscopy (FB). However, routine use of moderate sedation during FB is controversial because its efficacy and safety are not well established.This study aims to evaluate the efficacy and safety of moderate sedation during FB.A search was made of Medline, EMBASE, and the Cochrane Library to May 2014.Randomized controlled trials (RCTs) and quasi-RCTs were included.The main analysis was designed to examine the efficacy of moderate sedation during FB in sedation than no-sedation.The willingness to repeat FB was significantly more in sedation than no-sedation (odds ratio [OR] 2.30; 95% confidence interval [CI] 1.11–4.73; P = 0.02; I2 = 22.5). The duration of FB was shorter in sedation group than no-sedation group (standardized mean difference [SMD] −0.21; 95% CI −0.38 to −0.03; P = 0.02; I2 = 78.3%). Event of hypoxia was not significantly different between sedation and no-sedation groups (OR 0.86; 95% CI 0.42–1.73; P = 0.67; I2 = 0%). The SpO2 during procedure was not different between sedation and no-sedation groups (SMD −0.14; 95% CI −0.37 to 0.08; P = 0.21; I2 = 49.9%). However, in subgroup analysis without supplemental oxygen, the SpO2 was significantly lower in sedation than no-sedation group (SMD −0.45; 95% CI −0.78 to −0.11; P = 0.01; I2 = 0.0%).According to this meta-analysis, moderate sedation in FB would be useful in patients who will require repeated bronchoscopies as well as safe in respiratory depression. To our knowledge, although the various sedative drugs are already used in the real field, this analysis was the first attempt to quantify objective results. We anticipate more definite and studies designed to elucidate standardized outcomes for moderate sedation in FB. 相似文献
5.
6.
In this paper, we introduce a new type of troubled-cell indicator to improve
hybrid weighted essentially non-oscillatory (WENO) schemes for solving the hyperbolic conservation laws. The hybrid WENO schemes selectively adopt the high-order
linear upwind scheme or the WENO scheme to avoid the local characteristic decompositions and calculations of the nonlinear weights in smooth regions. Therefore,
they can reduce computational cost while maintaining non-oscillatory properties in
non-smooth regions. Reliable troubled-cell indicators are essential for efficient hybrid
WENO methods. Most of troubled-cell indicators require proper parameters to detect
discontinuities precisely, but it is very difficult to determine the parameters automatically. We develop a new troubled-cell indicator derived from the mean value theorem
that does not require any variable parameters. Additionally, we investigate the characteristics of indicator variable; one of the conserved properties or the entropy is considered as indicator variable. Detailed numerical tests for 1D and 2D Euler equations are
conducted to demonstrate the performance of the proposed indicator. The results with
the proposed troubled-cell indicator are in good agreement with pure WENO schemes.
Also the new indicator has advantages in the computational cost compared with the
other indicators. 相似文献
7.
8.
9.
10.